greeksoup/ stock research

Dolby Laboratories (DLB) FY2023 results: revenue $1.3 billion, up 3.7% on the year

Dolby Laboratories, Inc. (DLB) reported revenue of $1.3 billion for fiscal 2023, the year ended 29 September 2023, up 3.7% on the year before. Net income was $201 million, up 9.0%, and diluted earnings per share $2.05. The figures are the company's own, from the 10-K it filed with the SEC on 17 November 2023.

Revenue
$1.3 billion
+3.7% on the year
FY2016FY2023
Operating margin
16.6%
16.5% a year earlier
FY2016FY2023
Net income
$201 million
+9.0% on the year
FY2016FY2023
Diluted EPS
$2.05
+13.3% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue1,3001,2541,281+3.7%
Cost of revenue153141130+7.9%
Gross profit1,1471,1121,151+3.1%
Gross margin88.3%88.7%89.9%
Research and development272261254+4.0%
Operating income216207344+4.4%
Operating margin16.6%16.5%26.9%
Interest expensen/a0.40.5
Pre-tax income250215355+16.2%
Income tax48.431.436.7+54.3%
Effective tax rate19.4%14.6%10.3%
Net income201184310+9.0%
Net margin15.4%14.7%24.2%
Diluted EPS$2.05$1.81$2.97+13.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow367319448+15.2%
Capital expenditure30.347.954.5-36.7%
Free cash flow337271393+24.4%
Free cash flow margin25.9%21.6%30.7%
Cash from investing54.2-296-44.9
Cash from financing-237-611-253
Depreciation and amortisation82.688.595.9-6.7%
Share-based compensation11811599.7+3.1%
Buybacks149530246-71.9%
Dividends paid10310089.2+3.3%
Dividend per share$1.11$1.02$0.91+8.8%
Diluted shares, weighted98m102m105m-4.2%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity2,3552,2462,598+4.8%
Non-controlling interest17.14.86.3+253.2%
Debt0.00.00.0
Operating lease liabilities37.037.756.7-1.8%
Other liabilities571401445+42.3%
Total liabilities and equity2,9802,6903,106+10.8%
Fixed assets482513534-6.2%
Goodwill408365341+11.8%
Intangible assets167112123+49.1%
Investments237292102-18.8%
Cash and equivalents7456201,225+20.2%
Receivables262244233+7.7%
Inventory35.623.511.0+51.3%
Other assets642520537+23.6%
Total assets2,9802,6903,106+10.8%

10-K for the year ended 29 September 2023, filed 17 November 2023: the filing.